 |
 |
 |
| 1. |
Kikuta K, Gotoh M, Kanda T, Tochigi N, Shimoda T, Hasegawa T, Katai H, Shimada Y, Suehara Y, Kawai A, Hirohashi S, Kondo T. Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities. Jpn J Clin Oncol 40: 60-72, 2010. |
| 2. |
Yonemori K, Tsuta K, Ono M, Shimizu C, Hirakawa A, Hasegawa T, Hatanaka Y, Narita Y, Shibui S, Fujiwara Y. Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer. Cancer 116: 302-308, 2010. |
| 3. |
Noguchi H, Mitsuhashi T, Seki K, Tochigi N, Tsuji M, Shimoda T, Hasegawa T. Fluorescence in situ hybridization analysis using EWSR1 and NR4A3 probes in extraskeletal myxoid chondrosarcomas. Hum Pathol 41: 336-342, 2010. |
| 4. |
Matsumura T, Yamaguchi T, Tochigi N, Wada T, Yamashita T, Hasegawa T. Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridization. J Clin Pathol 63: 124-128, 2010. |
| 5. |
Hashimoto K, Hisasue S, Masumori N, Kobayashi K, Kato R, Fukuta F, Takahashi A, Hasegawa T, Tsukamoto T. Clinical safety and feasibility of a newly developed, simple algorithm for decision-making on neurovascular bundle preservation in radical prostatectomy. Jpn J Clin Oncol 40: 343-348, 2010. |
| 6. |
Yonemori K, Tsuta K, Shimizu C, Hatanaka Y, Hirakawa A, Ono M, Kouno T, Katsumata N, Ando M, Tamura K, Hasegawa T, Kinoshita T, Fujiwara Y. Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy. J Surg Oncol 101: 222-227, 2010. |
| 7. |
Shioi Y, Hasegawa T, Otsuka K, Fujisawa K, Itabashi T, Kimura T, Wakabayashi G, Mue Y, Uesugi N, Sugai T. Primary retroperitoneal spindle cell liposarcoma: pathological and immunohistochemical findings. Pathol Int 60: 472-476-2010. |
| 8. |
Sakamoto K, Sakurai S, Kanda T, Sakuma Y, Hishima T, Hironaka M, Bamba T, Keira Y, Takano Y, Niki T, Hasegawa T, Hirota S. Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment. Cancer Sci 101: 1270-1278, 2010. |
| 9. |
Igarashi S, Suzuki H, Niinuma T, Shimizu H, Nojima M, Iwaki H, Nobuoka T, Nishida T, Miyazaki Y, Takamaru H, Yamamoto E, Yamamoto H, Tokino T, Hasegawa T, Hirata K, Imai K, Toyota M, Shinomura Y. A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors. Clin Cancer Res 16: 5114-5123, 2010. |
| 10. |
Suzuki K, Momota H, Tonooka A, Noguchi H, Yamamoto K, Wanibuchi M, Minamida Y, Hasegawa T, Houkin K. Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature. J Neurooncol 99: 147-153, 2010. |
| 11. |
Ogino J, Asanuma H, Sakurai S, Matsuno Y, Miyokawa N, Yamashiro K, Fukazawa Y, Muraoka S, Iwaki Y, Kondo N, Hasegawa T. Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors. Pathol Int 60: 707-713, 2010. |
| 12. |
Shimizu T, Ishikawa T, Sugihara E, Kuninaka S, Miyamoto T, Mabuchi Y, Matsuzaki Y, Tsunoda T, Miya F, Morioka H, Nakayama R, Kobayashi E, Toyama Y, Kawai A, Ichikawa H, Hasegawa T, Okada S, Ito T, Ikeda Y, Suda T, Saya H. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Oncogene 29: 5687-5699, 2010. |
| 13. |
Nakayama R, Mitani S, Nakagawa T, Hasegawa T, Kawai A, Morioka H, Yabe H, Toyama Y, Ogose A, Toguchida J, Nakayama T, Yoshida T, Ichikawa H. Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type. Am J Surg Pathol 34: 1599-1607, 2010. |
| 14. |
Suzuki K, Matsui Y, Endo K, Kubo T, Hasegawa T, Kimura T, Ohtani O, Yasui N. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene. Anticancer Res 30: 4679-4684, 2010. |
| 15. |
長谷川匡. 淡明細胞肉腫. 整形外科 2010; 61: 170-171. |
| 16. |
長谷川匡. 軟部腫瘍の遺伝子診断（第56回学術集会シンポジウム3: 軟部腫瘍の病理診断における新展開(3)）. 臨床病理 2010; 58: 371-381. |
| 17. |
長谷川匡, 荻野次郎, 浅沼広子, 櫻井信司. GIST病理診断標準化のための免疫染色（役に立つ免疫組織化学-免疫組織化学で注目すべき抗体）. 検査と技術 2010; 38: 426-428. |
| 18. |
三橋智子. 筋線維芽細胞. 病理形態学キーワード. 病理と臨床 臨時増刊号 2010; 28: 363-363. |
| 19. |
三橋智子. 胃型管状腺腫の最近の概念について（今月の話題）. 病理と臨床 2010; 28: 541-543. |
| 20. |
三橋智子（分担執筆）. 婦人科病理診断トレーニング（編集 清水道生）. 東京：医学書院 2010. |
| 21. |
外岡暁子, 計良淑子, 荻野次郎, 菊地智樹, 香月奈穂美, 串田吉生, 羽場礼次, 長谷川匡. 偽血管腔構造が特徴的な皮膚髄膜腫. 診断病理 2010; 27: 36-39. |
| 22. |
計良淑子, 菊地智樹, 外岡暁子, 荻野次郎, 中西勝也, 野口寛子, 三橋智子, 長谷川匡. 若年成人女性の骨盤腔内に発生した胎児型横紋筋肉腫、紡錘形細胞亜型の1例. 診断病理 2010; 27: 123-127. |
| 23. |
長谷川匡. II. 診断 1. 臨床病理における最近の進歩 6) FISHによるキメラ遺伝子の検出-軟部肉腫-. 整形外科 61: 769-776, 2010. |
| 24. |
関邦彦, 長谷川匡. 第2部 組織型と診断の実際. III. 非上皮性腫瘍. B. 軟部腫瘍. 黒住昌史ら編. 腫瘍病理鑑別診断アトラス 乳癌. 文光堂. 東京. 2010年. 143-149. |
| 25. |
長谷川匡. 第18章 骨・軟部. 脱分化型腫瘍. 病理と臨床 臨時増刊号 2010; 28: 360-361. |
| 26. |
長谷川匡. 免疫反応と臨床検査2010. VIII章 病理・細胞診. 6 非上皮性腫瘍. 検査と技術 2010; 38: 1016-1021. |
| 27. |
小田義直, 長谷川匡ら. シンポジウム 骨・軟部腫瘍の病理診断の問題点. 生検標本による軟部肉腫の組織型・悪性度判定における病理診断の問題点. 日整会誌 2010; 84: 1114-1119. |
| 28. |
石田剛, 長谷川匡ら. シンポジウム 骨・軟部腫瘍の病理診断の問題点. Ewing肉腫の病理診断上の問題点. 日整会誌 2010; 84: 1126-1131. |
| 29. |
近藤啓, 東恭悟, 浅沼広子, 青山智志, 佐々木雅博, 遠藤明美, 大井由紀子, 野口寛子, 三橋智子, 鈴木孝浩, 齋藤豪, 長谷川匡. 腺癌との鑑別が困難であったgoblet cell carcinoidの一例. 日臨細胞北海道会報 2010; 19: 26-29. |
|
|
 |
